Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

493 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Ruxolitinib for steroid-refractory chronic graft-versus-host disease: Japanese subgroup analysis of REACH3 study.
Shiratori S, Fukushima K, Onishi Y, Doki N, Goto T, Okada M, Nakamae H, Maeda Y, Kato K, Ishikawa T, Kondo T, Toyosaki M, Ikeda T, Uchida N, Maki A, Shimada F, Tajima T, Stefanelli T, Teshima T. Shiratori S, et al. Among authors: maki a. Int J Hematol. 2024 Oct 3. doi: 10.1007/s12185-024-03850-9. Online ahead of print. Int J Hematol. 2024. PMID: 39361234
Ruxolitinib in steroid-refractory acute graft-vs-host disease: Japanese subgroup analysis of the randomized REACH2 trial.
Teshima T, Onishi Y, Kato K, Taniguchi S, Miyamura K, Fukushima K, Kato J, Ishikawa T, Doki N, Nakamae H, Maeda Y, Inamoto Y, Okada M, Maki A, Shimada F, Tajima T, Wroclawska M, Zeiser R, Onizuka M. Teshima T, et al. Among authors: maki a. Int J Hematol. 2024 Jul;120(1):106-116. doi: 10.1007/s12185-024-03772-6. Epub 2024 May 25. Int J Hematol. 2024. PMID: 38796666 Free PMC article. Clinical Trial.
Asciminib in Patients With CML-CP Previously Treated With ≥ 2 Tyrosine Kinase Inhibitors: 96-Week Results From the Japanese Subgroup Analysis of the ASCEMBL Study.
Minami Y, Doki N, Matsuoka H, Yokota T, Tomita A, Takahashi N, Kubo K, Goto T, Kirito K, Maki A, Aoki M, Dawson MK, Matsumura I. Minami Y, et al. Among authors: maki a. Int J Hematol. 2024 Sep;120(3):305-313. doi: 10.1007/s12185-024-03805-0. Epub 2024 Jun 18. Int J Hematol. 2024. PMID: 38888812 Free PMC article. Clinical Trial.
Reduced-port robotic pancreaticoduodenectomy with optimized surgical field deployment: early results of single-site plus-two ports method.
Ninomiya R, Komagome M, Abe S, Maruta S, Matsudaira S, Okada N, Mori K, Nagata R, Chiyoda T, Kimura A, Takemura N, Maki A, Beck Y, Hsieh CL, Peng CM. Ninomiya R, et al. Among authors: maki a. Surg Endosc. 2024 Sep;38(9):5422-5429. doi: 10.1007/s00464-024-11097-y. Epub 2024 Jul 24. Surg Endosc. 2024. PMID: 39048737 Free PMC article.
493 results